Blokhin's Russian Cancer Research Center

This study is testing whether a combination of three drugs (irinotecan, dabrafenib, and trametinib) plus a targeted antibody (cetuximab or panitumumab) can help control advanced colorectal cancer that has spread and carries a specific BRAF gene mutation. It is for patients whose …

This study looks back at the medical records of 230 patients to understand how different treatments for brain metastases from stomach or esophageal cancer affect survival. Researchers are comparing surgery, radiation, and combinations of these treatments. The goal is to find whic…

This study looks back at the medical records of 700 patients from Russia and Belarus to understand which treatments work best when colorectal cancer spreads to the brain. Researchers are analyzing past surgeries and radiation therapies to see which approaches helped patients live…

This study aims to understand which treatment sequences work best for patients whose aggressive brain tumors have returned. Researchers will analyze the medical records of about 1,000 patients to see how different chemotherapy and targeted drug combinations affect survival and ti…